FDA Investigator Dr. Yubing Tang

Dr. Yubing Tang has conducted inspections on 8 sites in 4 countries as of 25 Oct 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

25 Oct 2023

Investigator Role:

FDA Investigator

Redica ID:

100008804

Countries of Inspections:

United States of America, Canada, China, Spain

FDA Investigators that have inspected at least one site in common with Dr. Yubing Tang:

Alice S Tsao, Alison N Stieg, Amy M Cramer, Anita R Michael, Anthony J Donato, Barbara A Gullick, Bijoy Panicker, Brooke K Higgins, Cedar H Boakye, Chaltu Nwakijra, Charles D Brown, Chiang Syin, PhD, Christina K Theodorou, Christine I Shaw, Christopher R Czajka, Christopher T Middendorf, Claire M Minden, Daniel L Zheng, David A Oluwo, David J Hafner, Douglas A Campbell, Dr. Dominick Roselle, Dr. Roslyn F Powers, Edmund F Mrak, Jr, Emest F Bizjak, Frederick F Razzaghi, George Pyramides, Hector Jcolon Torres, James M Mason, James M Simpson, James Norman, Jenny Sung, Jonah S Ufferfilge, Jonathan G Matrisciano, Jonathan W Chapman, Joseph W Matthews, Junho Pak, Kathleen M Jordan, Kenneth M Gordon, Kenneth Nieves, Ko U Min, Kristina J Donohue, Kristina L Conroy, Lawrence Harmon, Jr, LCDR Susan E Polifko, Lori S Lawless, Marcellinus D Dordunoo, Marcus A Ray, Margaret M Doherty, Matthew M Henciak, Melissa J Garcia, Michael L Casner, Michael Serrano, Michael Shanks, MS, Mindy M Chou, Nebil A Oumer, Nicholas A Violand, Nicola M Fenty Stewart, Nicole E Knowlton, Paul L Bellamy, Rachael O Oyewole, Rachel C Harrington, Robert J Martin, Samantha J Bradley, Sharon K Thoma, PharmD, Shirshendu K Deb, PhD, Simone E Pitts, Srinivas R Chennamaneni, PhD, Stephenie M Ortiz, Suchan Kim, Thomas J Arista, Tonia F Bernard, Toyin B Oladimeji, Ucheabuchi Cchudi Nwankwor, Viviana Matta, Vivin George, Walter L Fava, Wanda Y Honeyblue, Yvesna C Blaise, Yvins Dezan, Zhongren Wu

Dr. Yubing Tang's Documents

Publish Date	Document Type	Title
August, 2018	EIR	Evonik Corporation - EIR, 2018-08-10
April, 2018	FDA 483	Amneal Pharmaceuticals LLC - Form 483, 2018-04-06
October, 2023	FDA 483	Nordson Medical Design and Development, Inc. - Form 483, 2023-10-31
April, 2018	EIR	Amneal Pharmaceuticals LLC - EIR, 2018-04-06
August, 2018	FDA 483	Evonik Corporation - Form 483, 2018-08-10
December, 2010	FDA 483	Pharmaceutics International, Inc. - Form 483, 2010-12-16

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more